Study: Targeted drug combos block tumor cell growth

09/13/2007 |

A combination of targeted cancer drugs, also known as receptor tyrosine kinases, can outsmart tumor cells by preventing protein switches from inciting cell growth, U.S. researchers report. However, scientists said further studies are needed before the combination treatments can be recommended to cancer patients, given the drugs' possible toxicity risk and high cost.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA